|
Volumn 148, Issue 1, 1995, Pages 39-44
|
Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus
|
Author keywords
cardiomyocytes; cardiomyopathy; cis parinaric acid; diabetes mellitus; fatty acids; fluorescence; hydralazine; plasma membrane fatty acid binding protein; trans parinaric acid
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
FATTY ACID BINDING PROTEIN;
HYDRALAZINE;
PARINARIC ACID;
STREPTOZOCIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CARDIOMYOPATHY;
CELL MEMBRANE;
CONTROLLED STUDY;
DIABETES MELLITUS;
MALE;
NONHUMAN;
RAT;
ANIMAL;
ANTIHYPERTENSIVE AGENTS;
ANTILIPEMIC AGENTS;
CARRIER PROTEINS;
DIABETES MELLITUS, EXPERIMENTAL;
FATTY ACIDS, UNSATURATED;
HYDRALAZINE;
HYPERLIPIDEMIA;
LIPIDS;
MALE;
MYELIN P2 PROTEIN;
MYOCARDIUM;
RATS;
RATS, WISTAR;
STREPTOZOCIN;
SUPPORT, NON-U.S. GOV'T;
ANIMALIA;
|
EID: 0029047773
PISSN: 03008177
EISSN: 15734919
Source Type: Journal
DOI: 10.1007/BF00929501 Document Type: Article |
Times cited : (7)
|
References (11)
|